Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV II Infection”

554 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 554 results

Testing effectiveness (Phase 2)Study completedNCT01067690
What this trial is testing

Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's Sarcoma

Who this might be right for
Kaposi's Sarcoma
Barbara Ensoli, MD, PhD 25
Early research (Phase 1)Study completedNCT00000810
What this trial is testing

Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Testing effectiveness (Phase 2)UnknownNCT01529073
What this trial is testing

Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection

Who this might be right for
HCV CoinfectionHIV Infection
Juan Macías 45
Not applicableStudy completedNCT00891644
What this trial is testing

Linkage to Care - Part II

Who this might be right for
HIVCare-seekingHIV Infections
University of North Carolina, Chapel Hill 59
Early research (Phase 1)Study completedNCT00006509
What this trial is testing

The Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Early research (Phase 1)Study completedNCT00002100
What this trial is testing

Phase I/II Study of Curdlan Sulfate

Who this might be right for
HIV Infections
AJI Pharma USA
Testing effectiveness (Phase 2)Ended earlyNCT00294372
What this trial is testing

Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected, NNRTI-treated Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 36
Testing effectiveness (Phase 2)Ended earlyNCT00300573
What this trial is testing

Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Incyte Corporation 250
Testing effectiveness (Phase 2)Study completedNCT00002423
What this trial is testing

Compare Two Anti-HIV Drug Combinations That Include Amprenavir in HIV-Infected Patients Who Have Failed Anti-HIV Drug Combinations That Did Not Include Amprenavir

Who this might be right for
HIV Infections
Glaxo Wellcome 100
Testing effectiveness (Phase 2)WithdrawnNCT00029250
What this trial is testing

Garlic in Hyperlipidemia Caused by HAART

Who this might be right for
HIV InfectionsHypercholesterolemiaHypertriglyceridemia+1 more
National Center for Complementary and Integrative Health (NCCIH)
Testing effectiveness (Phase 2)Study completedNCT00000885
What this trial is testing

Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 440
Testing effectiveness (Phase 2)Study completedNCT00126880
What this trial is testing

AVX754 (a New Nucleoside Reverse Transcriptase Inhibitor [NRTI]) to Treat Drug-resistant HIV

Who this might be right for
HIV Infections
Avexa 52
Testing effectiveness (Phase 2)Study completedNCT00002185
What this trial is testing

A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3

Who this might be right for
Sarcoma, KaposiHIV Infections
Agouron Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT00145249
What this trial is testing

Amphotericin Alone or in Combination With Fluconazole for AIDS-Associated Meningitis

Who this might be right for
Cryptococcal Meningitis
National Institute of Allergy and Infectious Diseases (NIAID) 143
Testing effectiveness (Phase 2)Study completedNCT01299948
What this trial is testing

Progression of HIV-Disease Under Low Dose Corticosteroids

Who this might be right for
HIV Disease Progression
Medical Mission Institute, Germany 326
Testing effectiveness (Phase 2)Study completedNCT01734850
What this trial is testing

Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 Infection

Who this might be right for
Human Immunodeficiency Virus
Calimmune, Inc. 13
Not applicableNot Yet RecruitingNCT07569913
What this trial is testing

Evaluate the Performance, and Usability of TruPlex HIV/HepB/Syphilis Rapid Test

Who this might be right for
HIV1 InfectionHIV 2 InfectionSyphilis Infection+1 more
bioLytical Laboratories 500
Testing effectiveness (Phase 2)Study completedNCT00000626
What this trial is testing

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

Who this might be right for
HIV InfectionsHodgkin's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Study completedNCT01516593
What this trial is testing

Short Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt Lymphoma

Who this might be right for
HIVBurkitt's Lymphoma
Andres J. M. Ferreri 19
Testing effectiveness (Phase 2)Study completedNCT01057121
What this trial is testing

Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma

Who this might be right for
AIDS-Related Kaposi SarcomaRecurrent Kaposi Sarcoma
National Cancer Institute (NCI) 38
Next Page